Limited Period Offer:Be a PRO for 1 month @Rs49/-Multiple payment options available. Know More
you are here: HomeNewscompanies

Amazon India to delist COVID-19 products priced above MRP

Amazon India said some sellers were attempting to raise prices beyond the MRP on certain products amidst the pandemic.

April 28, 2021 / 01:11 PM IST
There is no place for price gouging on Amazon, the firm said. Representative image

There is no place for price gouging on Amazon, the firm said. Representative image

In a bid to prevent profit gouging, Amazon India has said it is in the process of removing listings of COVID-19 products priced above MRP.

Amid the second wave of COVID-19 and paucity of medical supplies, many sellers have tried to make extra profit by selling products at prices higher than the Maximum Retail Price (MRP).

Amazon said that it was disappointed with some sellers as they were "attempting to raise prices beyond the MRP on certain products amidst the pandemic".

Track this LIVE blog for latest update on coronavirus pandemic

"There is no place for price gouging on Amazon and in line with our policy we continue to actively monitor our marketplace and take necessary action including removal of listings and suspension of accounts against sellers who are selling products above the MRP, which is in violation of Indian laws," the e-commerce platform said.

Close

COVID-19 Vaccine

Frequently Asked Questions

View more
How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

View more
Show

Amazon India, on April 27, announced that it had procured 100 ventilators and would import these to India in its bid to help the country fight the devastating second wave of COVID-19.

"Amazon has worked with the Ministry of Health and Family Welfare to ensure the ventilators are of acceptable technical specification and carried out its own compatibility checks to immediately fund 100 units of Medtronic's PB980 model and bring them into India for urgent use," the company shared in a blogpost.

Click here for Moneycontrol's full coverage of the COVID-19 outbreak
Moneycontrol News
first published: Apr 28, 2021 01:11 pm

stay updated

Get Daily News on your Browser
Sections